iSpecimen Inc. (NASDAQ:ISPC) Short Interest Down 99.1% in April

iSpecimen Inc. (NASDAQ:ISPC) was the recipient of a significant decline in short interest during the month of April. As of April 30th, there was short interest totaling 51,489 shares, a decline of 99.1% from the April 15th total of 5,529,018 shares. Currently, 7.9% of the shares of the company are short sold. Based on an average trading volume of 1,959,292 shares, the days-to-cover ratio is currently 0.0 days.

iSpecimen Stock Performance

iSpecimen stock opened at $4.76 on Tuesday. iSpecimen has a fifty-two week low of $4.00 and a fifty-two week high of $127.20. The stock has a market cap of $3.52 million, a P/E ratio of -0.05 and a beta of 1.75. The firm’s fifty day moving average price is $6.75 and its 200-day moving average price is $13.78.

Analysts Set New Price Targets

A number of equities research analysts recently commented on ISPC shares. Wall Street Zen raised shares of iSpecimen to a “sell” rating in a report on Saturday, May 2nd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of iSpecimen in a report on Tuesday, April 21st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in iSpecimen stock. Scientech Research LLC bought a new stake in shares of iSpecimen Inc. (NASDAQ:ISPC) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 29,488 shares of the company’s stock, valued at approximately $38,000. Scientech Research LLC owned about 0.30% of iSpecimen at the end of the most recent reporting period. Institutional investors and hedge funds own 13.62% of the company’s stock.

iSpecimen Company Profile

iSpecimen, Inc (NASDAQ:ISPC) operates an online life sciences marketplace designed to connect researchers with human biological specimens and associated clinical data. The company’s platform streamlines the sourcing of biospecimens—such as plasma, serum, fresh and frozen tissue, saliva, urine and peripheral blood mononuclear cells (PBMCs)—by matching demand from pharmaceutical, biotechnology, diagnostic and academic organizations with supply from a wide network of clinical sites and biobanks.

Through its on-demand procurement model, iSpecimen provides customized specimen collection and fulfillment services that help accelerate research timelines and improve data quality.